CDC recommends 2nd bivalent booster for seniors, immunocompromised

The CDC backed changes to the COVID-19 vaccination schedule on April 19, simplifying recommendations and including a second bivalent booster authorized by the FDA April 18 for senior populations and people who are immunocompromised.

Advertisement

According to published guidelines, people 65 and older can receive the second bivalent booster four months after their last vaccine dose.

For people who are immunocompromised, the second bivalent booster can be received two months after receiving their last vaccine. 

Authorization of the monovalent vaccines from Moderna and Pfizer was rescinded by the FDA. This means anyone who is unvaccinated can now receive one dose of the bivalent vaccine.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.